Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Closing Bell 14 November

Grady Wulff
November 14, 2022

Morning Bell 14 November

Grady Wulff
November 14, 2022

Weekly Wrap 11 November

Grady Wulff
November 11, 2022

Morning Bell 11 November

Sophia Mavridis
November 11, 2022

Morning Bell 10 November

Grady Wulff
November 10, 2022

Closing Bell 9 November

Sophia Mavridis
November 9, 2022

Morning Bell 9 November

Grady Wulff
November 9, 2022

Closing Bell 8 November

Grady Wulff
November 8, 2022

Morning Bell 8 November

Sophia Mavridis
November 8, 2022

Closing Bell 7 November

Grady Wulff
November 7, 2022

Morning Bell 7 November

Grady Wulff
November 7, 2022